C

Cytokinetics

Develops small-molecule therapies for muscle function

Director – Strategy & Business Development

Corporate StrategyConfirmed live in the last 24 hours
Full-timeSouth San Francisco, CA, USA$235.8k - $275.1k

About the Job

Requirements

  • At least 4 years of experience across strategy consulting, investment banking, corporate strategy, or biotech/pharmaceutical business development.
  • Ability to build top-down drug revenue forecasts and commercial models from epidemiology, pricing, and uptake assumptions.
  • Strong quantitative and financial-modeling skills, including rNPV, discounted cash flow, comparable transactions, scenario analysis, and sensitivity analysis.
  • Ability to structure ambiguous problems into decision-ready recommendations.
  • Fluency with large language model tooling and prompt engineering, and ability to build lightweight automations and take an artificial intelligence use case from proof of concept to adoption.
  • Ability to communicate with executives and establish credibility with senior leaders and the Board.

Responsibilities

  • Own and build first-pass, top-down drug revenue forecasts using epidemiology, diagnosis and treatment rates, pricing, and penetration and peak-share assumptions to produce timely and defensible commercial forecasts.
  • Develop and apply valuation models based on forecasts, including rNPV, scenario and sensitivity analysis, and out-licensing and deal modeling; translate model results into implications, trade-offs, and recommendations for business development and senior leadership.
  • Challenge and pressure-test commercial assumptions and forecast iterations to strengthen the quality of business development forecasts and valuations.
  • Own and continuously improve reusable forecast, valuation, comparable-company, and screening templates to improve the speed, consistency, and quality of business development decisions.
  • Support ad hoc business development analysis and tooling, including methodology and scoring design for screening large scientific-congress datasets to identify assets.
  • Support the annual strategic planning cycle and August Board presentation from narrative development through analysis and synthesis.
  • Own and continuously improve cross-functional planning inputs and templates spanning Finance, Research and Development, and Commercial.
  • Support program management of the company's artificial intelligence initiative, including intake and triage, prioritization, cadence, and governance-development support reviewed with IT across the Company Operating Committee, Senior Leadership Team, and Executive Committee.
  • Engage internal stakeholders; build templates and enablement for artificial intelligence champions; and maintain the library and repository of artificial intelligence use cases with those champions.
  • Coordinate artificial intelligence content for Company Operating Committee, Senior Leadership Team, Executive Committee, and Board materials.
  • Deliver ad hoc executive analyses, including most-favored-nation and drug-pricing differential analysis and red-team analysis.

Desired Qualifications

  • An MBA, PhD, MD, or equivalent qualification is a plus.
  • Therapeutic fluency, particularly in cardiovascular or rare disease, is a plus.

About the Company

Cytokinetics

Develops small-molecule therapies for muscle function

Cytokinetics develops and commercializes small molecule drugs aimed at improving muscle function for cardiovascular and neuromuscular diseases. Its products are designed to either enhance or adjust muscle contraction, with a pipeline that includes compounds like omecamtiv mecarbil, reldesemtiv, CK-274, AMG 594, and CK-601, currently in various stages of clinical trials. The company advances therapies through partnerships, licensing, and potential sales of approved medicines, and relies on extensive clinical testing to demonstrate effectiveness and safety. What sets Cytokinetics apart is its focused approach on muscle function modulators (activators and inhibitors) for both heart and skeletal muscle diseases, targeting conditions such as heart failure, hypertrophic cardiomyopathy, ALS, and SMA. Its goal is to bring medicines to patients to improve muscle performance and daily function, addressing unmet medical needs in these diseases.

Company size
501-1,000
Company stage
IPO
Headquarters
South San Francisco, CA
Founded
1998

Recently Posted Jobs

Explore more opportunities at Cytokinetics

See more jobs